Eliot J. Walker Phone: 214-978-6614 Fax: 214-978-6601 Education
B.A., International Politics, with honors Western District of Texas Eastern District of Pennsylvania Eliot Walker practices complex civil litigation. Eliot has significant expertise in case strategy, targeted motion practice, and creative problem solving. His experience spans multiple substantive practice areas. Eliot began his career at Dechert LLP, where he represented pharmaceutical companies in multidistrict and other consolidated litigation. While at Dechert LLP, Eliot was a key member of AstraZeneca Pharmaceuticals’ legal team in nationwide litigation concerning Seroquel – prevailing on Daubert and summary judgment motions that defeated the lead bellwether plaintiffs’ cases. Upon moving to Dallas, Eliot joined the financial services litigation practice group of Kane Russell Coleman & Logan PC, where he represented financial institutions in complex litigation. Most recently, Eliot represented Comerica Bank in a federal class action consolidated in multidistrict proceedings in Florida, where he oversaw an innovative and cost-saving “predictive coding” discovery protocol, among other successes. At SKIERMONT PUCKETT LLP, Eliot represents clients in all types of complex litigation, including patent and commercial litigation. Eliot has experience in all phases of litigation, from initial pleadings through discovery, trial, and appeals. Eliot is also an active member of the Dallas legal community, where the Dallas Association of Young Lawyers (DAYL) recently recognized him as “One to Watch.” Eliot is a Steering Committee member of DAYL’s 2012 Leadership Class, a co-Chair of DAYL’s Animal Welfare Committee, and a member of the Dallas Asian American Bar Association. Representations
In re Checking Account Overdraft Litigation (MDL 2036) (Northern District of Texas; MDL Southern District of Florida;
Eleventh Circuit Court of Appeals)
Represented Comerica Bank in class action litigation concerning consumers’ claims for restitution of allegedly
wrongful overdraft fees. Responsibilities spanned all aspects of litigation. Developed and drafted dispositive and
Daubert motions before the MDL district court, as well as appellate briefing before the U.S. Court of Appeals for the
Eleventh Circuit. Resolved discovery dispute concerning the costly mass-production of electronically stored
information through implementation of a computer-assisted "predictive coding" document review protocol.
In re Seroquel Products Liability Litigation (MDL 1769) (District of Massachusetts; MDL Middle District of Florida)
Represented AstraZeneca Pharmaceuticals against product liability claims concerning the atypical antipsychotic
Seroquel. Successfully obtained defense summary judgment on the lead bellwether plaintiff's case, where the court
ruled that plaintiff's expert failed to employ a scientifically reliable methodology to establish medical causation. See
Haller v. AstraZeneca Pharms. LP
, 598 F. Supp. 2d 1271 (M.D. Fla. 2009); see also Guinn v. AstraZeneca Pharms.
, 598 F. Supp. 2d 1239 (M.D. Fla. 2009), aff’d 602 F.3d 1245 (11th Cir. 2010) (companion case). Eliot also
assisted the AstraZeneca trial team that secured a defense verdict in March 2010 from a New Jersey state court jury
in Baker v. AstraZeneca Pharms. LP., the first Seroquel case ever to go to trial.
Unishippers Global Logistics v. DHL Express (District of Utah)
Represented DHL Express in breach of contract litigation, serving as member of DHL’s trial team during two-week
federal jury trial. Prepared successful defense strategy concerning plaintiff’s claims for $13 million in alleged
“overcharge” damages, obtaining jury verdict of zero damages. Eliot also represented DHL Express in the related
case of Gulf Coast Shippers LP et al. v. DHL Express (District of Utah), where his responsibilities spanned all
aspects of pre-trial discovery and motion practice.
McWilliams v. Trustmark National Bank (Harris County District Court)
Represented Trustmark National Bank in breach of contract action.
Mitchell v. Mitchell et al. (Collin County District Court)
Represented Receiver of disputed funds in interpleader action.
In re Vioxx Products Liability Litigation
Represented pharmaceutical company in various consolidated mass-tort actions concerning the drug Vioxx.

Steering Committee Member, DAYL Leadership Class of 2012
Co-Chair, DAYL Animal Welfare Committee
Fellow, DAYL Foundation
Member, Dallas Asian American Bar Association
Member, Dallas Association of Young Lawyers
Member, Dallas Bar Association
Government Service and Academia
Judicial Extern for the Honorable Thomas J. McAvoy (Northern District of New York)
Research Analyst for the Center for Strategic and International Studies (Washington, D.C.)
Publications and Presentations
Banking Litigation Manual, BNA PUBLICATIONS (forthcoming 2014)
"Predictive Coding" Arrives: Automated Document Review System May Significantly Reduce Litigation Expenses in
Complex Cases
Simultaneous Trials Bring New Challenges to New Jersey Courts, N.J. LAWYER MAGAZINE, Aug. 2011, at 51

The Food Safety Modernization Act: A Review of the Act and Its Potential Impact on Private Litigation
In the Mix: FDA and Caffeinated Alcoholic Drinks, LAW 360, Nov. 22, 2010
Asylees in Wonderland: A New Procedural Perspective on America’s Asylum System, 2 NORTHWESTERN JOURNAL OF
Safe Harbor: Is Clark v. Martinez the End of the Voyage of the Mariel?, 39 CORNELL INTERNATIONAL LAW JOURNAL 121
Distinctions and Honors
Executive Editor, Cornell International Law Journal
Member, Phi Beta Kappa Society
"One to Watch," Dallas Association of Young Lawyers



OF ATHEROSCLEROSIS AND A POTENTIAL TARGETAtherosclerosis, and its devastating complications cerebral andmyocardial infarction and gangrene of the extremities, is the leadingcause of death. Atherogenesis in humans develops over many years,often reckoned in decades. Early lesion formation may even occur inadolescence. Lesion progression depends on genetic make-up, genderand certain well-recognized

About the scoop program:

Procedure Information ERCP Enquiries and appointments: (08) 73250068 Here are answers to some of the commonly asked questions about ERCP. Ask your doctor if you have additional questions or concerns. WHAT IS AN ERCP ? The term "ERCP” stands for endoscopic retrograde cholangio-pancreatography. This means looking inside the ducts or “drainage tubes” of the liver, ga

Copyright ©2018 Sedative Dosing Pdf